These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 28965628

  • 21. Simultaneous immunohistochemical localization of beta-catenin and cyclin D1 in differentiated but not in undifferentiated human endometrial carcinoma.
    Narita F, Sato A, Hamana S, Deguchi M, Otani T, Maruo T.
    Eur J Gynaecol Oncol; 2003; 24(2):129-34. PubMed ID: 12701961
    [Abstract] [Full Text] [Related]

  • 22. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T, Ersöz C, Uğuz A, Vardar MA, Altintaş A.
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. CyclinD1, a prominent prognostic marker for endometrial diseases.
    Liang S, Mu K, Wang Y, Zhou Z, Zhang J, Sheng Y, Zhang T.
    Diagn Pathol; 2013 Aug 15; 8():138. PubMed ID: 23947899
    [Abstract] [Full Text] [Related]

  • 29. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN, Han G, McConechy M, Lau S, Chow C, Gilks CB, Huntsman DG, Köbel M, Lee CH.
    Histopathology; 2014 Mar 15; 64(4):585-96. PubMed ID: 24103020
    [Abstract] [Full Text] [Related]

  • 30. Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells.
    Fakhry H, Miyamoto T, Kashima H, Suzuki A, Ke H, Konishi I, Shiozawa T.
    Hum Pathol; 2010 Jun 15; 41(6):848-58. PubMed ID: 20178884
    [Abstract] [Full Text] [Related]

  • 31. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium.
    Horn LC, Richter CE, Einenkel J, Tannapfel A, Liebert UG, Leo C.
    Ann Diagn Pathol; 2006 Aug 15; 10(4):193-6. PubMed ID: 16844559
    [Abstract] [Full Text] [Related]

  • 32. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
    Siu MK, Kong DS, Ngai SY, Chan HY, Jiang L, Wong ES, Liu SS, Chan KK, Ngan HY, Cheung AN.
    PLoS One; 2015 Aug 15; 10(7):e0133467. PubMed ID: 26218748
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.
    Ussakli C, Usubutun A, Dincer N, Dolgun A, Bülbül D, Isikdogan Z, Haberal N, Ozen O, Tezel GG.
    Pol J Pathol; 2016 Aug 15; 67(3):221-227. PubMed ID: 28155970
    [Abstract] [Full Text] [Related]

  • 35. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
    Dong Y, Sui L, Sugimoto K, Tai Y, Tokuda M.
    Int J Cancer; 2001 Jul 20; 95(4):209-15. PubMed ID: 11400112
    [Abstract] [Full Text] [Related]

  • 36. Immunohistochemical Analysis Of Novel Biomarkers Cyclin D1, p53 And Ki67 In Endometrial Carcinoma: Clinicopathological Significance And Prognostic Value.
    Atram MA, Shivkumar VB, Gangane NM.
    Gulf J Oncolog; 2022 Jan 20; 1(38):15-23. PubMed ID: 35156640
    [Abstract] [Full Text] [Related]

  • 37. Expression of Ki-67 as proliferation biomarker in imprint smears of endometrial carcinoma.
    Kosmas K, Stamoulas M, Marouga A, Kavantzas N, Patsouris E, Athanassiadou P.
    Diagn Cytopathol; 2013 Mar 20; 41(3):212-7. PubMed ID: 21965052
    [Abstract] [Full Text] [Related]

  • 38. Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1).
    Zagorianakou N, Ioachim E, Mitselou A, Kitsou E, Zagorianakou P, Stefanaki S, Makrydimas G, Agnantis NJ.
    Eur J Gynaecol Oncol; 2003 Mar 20; 24(6):500-4. PubMed ID: 14658589
    [Abstract] [Full Text] [Related]

  • 39. Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy.
    Abdelrahman AE, Fathy A, Elsebai EA, Nawar N, Etman WM.
    Ann Diagn Pathol; 2018 Aug 20; 35():27-37. PubMed ID: 30072015
    [Abstract] [Full Text] [Related]

  • 40. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes.
    Zheng W, Cao P, Zheng M, Kramer EE, Godwin TA.
    Gynecol Oncol; 1996 May 20; 61(2):167-74. PubMed ID: 8626128
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.